| Characteristic . | Whole Cohort (N = 914) . | Selected Cohort (N = 465) . |
|---|---|---|
| Sex (male) | 678 (74.3) | 392 (81.2) |
| Age at HIV diagnosis (years) | 33 (27–40) | 33 (27–40) |
| LTNP-Ca | 468 (52.8) | 241 (51.8) |
| Interferon-lambda 4 A/A genotypeb | NA | 224 (48.2) |
| HLA-B*27 | 127 (14.2) | 94 (20) |
| HLA-B*57 | 268 (29.9) | 134 (28.6) |
| HLA-B*35 | 85 (9.5) | 46 (9.8) |
| HLA-B*08 | 74 (8.3) | 53 (11.3) |
| Characteristic . | Whole Cohort (N = 914) . | Selected Cohort (N = 465) . |
|---|---|---|
| Sex (male) | 678 (74.3) | 392 (81.2) |
| Age at HIV diagnosis (years) | 33 (27–40) | 33 (27–40) |
| LTNP-Ca | 468 (52.8) | 241 (51.8) |
| Interferon-lambda 4 A/A genotypeb | NA | 224 (48.2) |
| HLA-B*27 | 127 (14.2) | 94 (20) |
| HLA-B*57 | 268 (29.9) | 134 (28.6) |
| HLA-B*35 | 85 (9.5) | 46 (9.8) |
| HLA-B*08 | 74 (8.3) | 53 (11.3) |
Qualitative data are no. (%) of individuals. and quantitative data are median (interquartile range).
Abbreviations: HIV, human immunodeficiency virus; HLA, human leukocyte antigen; LTNP-C, long-term nonprogressor HIV-1 controller; NA, not available in the whole cohort.
aLTNP-C classification was possible for 887 patients.
bData were available for 465 individuals, for whom characteristics are listed in the right column.
| Characteristic . | Whole Cohort (N = 914) . | Selected Cohort (N = 465) . |
|---|---|---|
| Sex (male) | 678 (74.3) | 392 (81.2) |
| Age at HIV diagnosis (years) | 33 (27–40) | 33 (27–40) |
| LTNP-Ca | 468 (52.8) | 241 (51.8) |
| Interferon-lambda 4 A/A genotypeb | NA | 224 (48.2) |
| HLA-B*27 | 127 (14.2) | 94 (20) |
| HLA-B*57 | 268 (29.9) | 134 (28.6) |
| HLA-B*35 | 85 (9.5) | 46 (9.8) |
| HLA-B*08 | 74 (8.3) | 53 (11.3) |
| Characteristic . | Whole Cohort (N = 914) . | Selected Cohort (N = 465) . |
|---|---|---|
| Sex (male) | 678 (74.3) | 392 (81.2) |
| Age at HIV diagnosis (years) | 33 (27–40) | 33 (27–40) |
| LTNP-Ca | 468 (52.8) | 241 (51.8) |
| Interferon-lambda 4 A/A genotypeb | NA | 224 (48.2) |
| HLA-B*27 | 127 (14.2) | 94 (20) |
| HLA-B*57 | 268 (29.9) | 134 (28.6) |
| HLA-B*35 | 85 (9.5) | 46 (9.8) |
| HLA-B*08 | 74 (8.3) | 53 (11.3) |
Qualitative data are no. (%) of individuals. and quantitative data are median (interquartile range).
Abbreviations: HIV, human immunodeficiency virus; HLA, human leukocyte antigen; LTNP-C, long-term nonprogressor HIV-1 controller; NA, not available in the whole cohort.
aLTNP-C classification was possible for 887 patients.
bData were available for 465 individuals, for whom characteristics are listed in the right column.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
